The Leukemia & Lymphoma Society (LLS) Therapy Acceleration Program® (TAP)

How can TAP benefit your company?

Hear what the SVP of Corporate & Business Development of Stemline Therapeutics has to say about TAP and the value created for his company beyond the funding amount. LLS TAP partnered with Stemline in 2013 to support key clinical studies for patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN).

 

   

Value Creation for Companies through LLS TAP: Dollars & Beyond 

Leadership provided an introduction to the LLS TAP venture philanthropy program and moderated a discussion panel with past and current TAP portfolio partners where you have the opportunity to hear how LLS TAP created value for each of the companies.

A recording of the presentation from Dec. 2020 is to the right.

 

  

Follow LLS